Syntheses of 11α-(3-carboxypropanoyloxy)-1α,25-dihydroxyvitamin D3and 11α(4-carboxybutanoyloxy)-1α,25-dihydroxyvitarnin D3: novel haptenic derivatives for production of highly specific antibodies to 1α,25-dihydroxyvitamin D31
摘要:
The measurement of serum/plasma levels of 1 alpha,25-dihydroxyvitamin D-3 1a is important for the diagnosis of diseases influencing vitamin D metabolism. To obtain antibodies to the metabolite 1a which are highly specific and useful for development of immunoassays, two novel haptenic derivatives. 11 alpha-(3-carboxypropanoyloxy)-1 alpha,25-dihydroxyvitamin D-3 2a and 11 alpha-(4-carboxybutanoyloxy)-1 alpha,25-dihydroxyvitamin D-3 2b were synthesized each in 19 steps from a suitably protected derivative (3) of 11 alpha,25-dihydroxycholesterol.
DOI:
10.1039/p19940001809
作为产物:
描述:
1α,2α-epoxy-3β,11α,25-trihydroxy-4'-phenyl-3',5'-dihydro-5,8-<1,2>epi<1,2,4>triazolo-5α,8α-cholest-6-ene-3',5'-dione 以
various solvent(s) 为溶剂,
生成 1α,2α-epoxy-cholesta-5,7-diene-3β,11α,25-triol
Production of Highly Specific Antibodies to 1.ALPHA.,25-Dihydroxyvitamin D3 Utilizing a Novel Haptenic Derivative Having a Chemical Bridge at 11.ALPHA.-Position.
The production of highly specific antibodies to 1 alpha,25-dihydroxyvitamin D3 1a utilizing a novel haptenic derivative 2, which was synthesized from 11 alpha,25-dihydroxycholesterol via 21 steps, has been reported. The properties of the obtained antibodies are also described.
Syntheses of 11α-(3-carboxypropanoyloxy)-1α,25-dihydroxyvitamin D<sub>3</sub>and 11α(4-carboxybutanoyloxy)-1α,25-dihydroxyvitarnin D<sub>3</sub>: novel haptenic derivatives for production of highly specific antibodies to 1α,25-dihydroxyvitamin D<sub>3</sub><sup>1</sup>
The measurement of serum/plasma levels of 1 alpha,25-dihydroxyvitamin D-3 1a is important for the diagnosis of diseases influencing vitamin D metabolism. To obtain antibodies to the metabolite 1a which are highly specific and useful for development of immunoassays, two novel haptenic derivatives. 11 alpha-(3-carboxypropanoyloxy)-1 alpha,25-dihydroxyvitamin D-3 2a and 11 alpha-(4-carboxybutanoyloxy)-1 alpha,25-dihydroxyvitamin D-3 2b were synthesized each in 19 steps from a suitably protected derivative (3) of 11 alpha,25-dihydroxycholesterol.